Lv35
280 积分 2021-05-21 加入
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD
6小时前
已关闭
Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents
1天前
已完结
IL-33 released during challenge phase regulates allergic asthma in an age-dependent way
2天前
已完结
Studies on the triterpenes from Bemeuxia thibetica Decne
2天前
已关闭
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
4天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
4天前
已完结
Asthma epidemiology and risk factors
15天前
已完结
Asthma
15天前
已完结
Diagnosis and management of ANCA-associated vasculitis
30天前
已完结
皖公网安备34019202002308
